AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BiomX, a clinical-stage company, has issued a statement in response to unusual trading activity in its common stock. The company is unaware of any material developments or reasons for the activity. NYSE American LLC contacted BiomX and advised the statement. BiomX does not intend to comment further on market speculation or trading activity.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet